MAGEA3 and ovarian cancer: By detecting the expression levels of BAGE, MAGE‐A1, MAGE‐A3, and GAGE1/‐2 in the ascites of patients with ovarian cancer, Hofmann et al.42found that the sensitivity of the combined diagnosis of the four markers was 94% compared with cell morphology alone.